ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,141Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 13

$481K Total Retail Price of All Prescriptions

Rank: 2 out of 13

391 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,874 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 595 506 1 1
SIMVASTATIN 445 381 2 2
FUROSEMIDE 429 371 3 4
HYDROCHLOROTHIAZIDE 413 369 4 10
OMEPRAZOLE 404 358 5 3
AMLODIPINE BESYLATE 356 317 6 9
POTASSIUM CHLORIDE 312 276 7 13
METOPROLOL TARTRATE 263 224 8 8
METFORMIN HCL 261 188 9 5
LOSARTAN POTASSIUM 244 215 10 25
ATENOLOL 241 203 11 12
CITALOPRAM HBR 237 192 12 15
ENALAPRIL MALEATE 214 158 13 23
WARFARIN SODIUM 182 161 14 7
GLIMEPIRIDE 175 160 15 32
METOPROLOL SUCCINATE 170 148 16 21
LISINOPRIL 162 145 17 5
HYDROCODONE-ACETAMINOPHEN 131 74 S3 18 11
GABAPENTIN 124 102 19 16
PRAVASTATIN SODIUM 123 92 20 18
ALENDRONATE SODIUM 121 121 21 24
AZITHROMYCIN 111 85 22 41
POLYETHYLENE GLYCOL 3350 107 107 23 46
MELOXICAM 106 94 24 50
DICLOFENAC SODIUM 105 81 25 48
FENOFIBRATE 104 87 26 57
CIPROFLOXACIN HCL 103 82 27 33
PAROXETINE HCL 99 82 28 31
ZOLPIDEM TARTRATE 97 25 29 27
TRAMADOL HCL 97 60 29 14
PANTOPRAZOLE SODIUM 95 88 31 56
EXELON 90 90 32 74
TRICOR 87 64 33 79
ATORVASTATIN CALCIUM 87 84 33 19
CLOPIDOGREL 87 83 33 63
OXYBUTYNIN CHLORIDE 85 66 36 85
ALLOPURINOL 83 75 37 22
TAMSULOSIN HCL 81 60 38 26
ALBUTEROL SULFATE 80 80 39 106
PROAIR HFA 79 49 40 39
CYCLOBENZAPRINE HCL 79 25 R 40 42
PREDNISONE 76 70 42 38
CARBIDOPA-LEVODOPA 73 53 43 61
LANTUS 72 59 44 43
ZETIA 69 54 45 86
LOVASTATIN 67 55 46 34
DIGOXIN 67 57 46 40
SERTRALINE HCL 66 58 48 36
TRIAMTERENE-HCTZ 63 63 49 20
PLAVIX 63 56 49 78
GLYBURIDE 60 29 R 51 60
SPIRIVA 60 45 51 62
PROPRANOLOL HCL 60 28 51 71
NEXIUM 59 28 54 35
ENALAPRIL-HYDROCHLOROTHIAZIDE 59 51 54 125
CLONIDINE HCL 58 51 56 126
DILTIAZEM 24HR CD 52 52 57 96
RAMIPRIL 51 51 58 138
CELEBREX 51 51 58 51
VENTOLIN HFA 50 27 60 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.